Improvement in Renal Function in High Immunologic Risk Kidney Transplant Recipients Switched From Tacrolimus to Belatacept

被引：1
|
作者：
Gupta, G. [1 ]
Kumar, D. [1 ]
Cotterell, A. [1 ]
Sharma, A. [1 ]
Posner, M. [1 ]
Ren, Q. [1 ]
Posner, S. [1 ]
King, A. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A203
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [1] Improvement in Renal Function in High Immunologic Risk Kidney Transplant Recipients Switched From Tacrolimus to Belatacept.
    Gupta, G.
    Kumar, D.
    Cotterell, A.
    Sharma, A.
    Posner, M.
    Ren, Q.
    Posner, S.
    King, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 457 - 457
  • [2] Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction
    Gupta, G.
    Regmi, A.
    Kumar, D.
    Posner, S.
    Posner, M. P.
    Sharma, A.
    Cotterell, A.
    Bhati, C. S.
    Kimball, P.
    Massey, H. D.
    King, A. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (10) : 2726 - 2731
  • [3] Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study
    Grinyo, Josep
    Alberu, Josefina
    Contieri, Fabiana L. C.
    Manfro, Roberto C.
    Mondragon, Guillermo
    Nainan, Georgy
    Rial, Maria del C.
    Steinberg, Steven
    Vincenti, Flavio
    Dong, Yuping
    Thomas, Dolca
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2012, 25 (10) : 1059 - 1064
  • [4] Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
    Efe, Orhan
    Al Jurdi, Ayman
    Eiting, Morgan Mabey
    Marks, Christine Rogers
    Cote, Mariesa Ann
    Wojciechowski, David
    Safa, Kassem
    Gilligan, Hannah
    Azzi, Jamil
    Goyal, Nitender
    Raynaud, Marc
    Loupy, Alexandre
    Weins, Astrid
    Riella, Leonardo V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients
    Wojciechowski, David
    Chandran, Sindhu
    Vincenti, Flavio
    CLINICAL TRANSPLANTATION, 2017, 31 (05)
  • [6] RENAL FUNCTION AT 2 YEARS IN KIDNEY TRANSPLANT RECIPIENTS SWITCHED FROM CYCLCOSPORINE OR TACROLIMUS TO BELATACEPT: RESULTS FROM THE LONG-TERM EXTENSION OF A PHASE II STUDY
    Grinyo, Josep
    Nainan, Georgy
    del Carmen Rial, Maria
    Steinberg, Steven
    Vincenti, Flavio
    Dong, Yuping
    Thomas, Dolca
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2011, 24 : 70 - 70
  • [7] Renal Function at 2 Years in Kidney Transplant Recipients Switched from Cyclosporine or Tacrolimus to Belatacept: Results from the Long-Term Extension of a Phase II Study
    Grinyo, J.
    Nainan, G.
    Rial, M.
    Steinberg, S.
    Vincenti, F.
    Dong, Y.
    Thomas, D.
    Kamar, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 99 - 99
  • [8] Belatacept in kidney transplant recipients switched from calcineurin inhibitors: results on renal function and safety after 6 months
    Bardo, P.
    Berdougo, B.
    Rouimi, E.
    Grimbert, P.
    Astier, A.
    Paul, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1301 - 1302
  • [9] Early Conversion to Belatacept in High Risk Renal Transplant Recipients
    Santeusanio, A.
    Bhansali, A.
    Shapiro, R.
    Delaney, V.
    Florman, S.
    De Boccardo, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 686 - 686
  • [10] Belatacept rescue therapy in kidney transplant recipients with severely impaired renal function
    Budde, Klemens
    Wiesener, Michael
    Kannenkeril, Dennis
    Durr, Michael
    Braun, Tobias
    Bachmann, Friederike
    Brakemeier, Susanne
    TRANSPLANTATION, 2016, 100 (07) : S82 - S83
12345